These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6154662)

  • 41. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
    Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
    Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells.
    Mantovani A; Sessa C; Peri G; Allavena P; Introna M; Polentarutti N; Mangioni C
    Int J Cancer; 1981; 27(4):437-46. PubMed ID: 6168590
    [No Abstract]   [Full Text] [Related]  

  • 44. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay.
    Abrams SI; Brahmi Z
    Ann Inst Pasteur Immunol; 1988; 139(4):361-81. PubMed ID: 3166753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
    Fukui H; Overton WR; Herberman RB; Reynolds CW
    J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The sensitivity of placental trophoblast cells to intraplacental and allogeneic cytotoxic lymphocytes.
    Pross H; Mitchell H; Werkmeister J
    Am J Reprod Immunol Microbiol; 1985 May; 8(1):1-9. PubMed ID: 4014527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of NK activity in effector cells purified from canine peripheral lymphocytes.
    Knapp DW; Leibnitz RR; DeNicola DB; Turek JJ; Teclaw R; Shaffer L; Chan TC
    Vet Immunol Immunopathol; 1993 Jan; 35(3-4):239-51. PubMed ID: 8430495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
    Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
    Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of human natural cell-mediated cytotoxicity by interferon.
    Moore M; Potter MR
    Br J Cancer; 1980 Mar; 41(3):378-87. PubMed ID: 6155926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG.
    Kay HD; Fagnani R; Bonnard GD
    Int J Cancer; 1979 Aug; 24(2):141-50. PubMed ID: 290570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of NK by cellular immunoadsorption.
    Jensen PJ; Koren HS
    J Immunol; 1979 Sep; 123(3):1127-32. PubMed ID: 89160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
    Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
    Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural killer activity and low-affinity E rosettes in acute leukemias.
    Matera L; Giancotti FG
    Acta Haematol; 1983; 70(3):158-62. PubMed ID: 6410642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.